SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

NCT04735042 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Urinary Tract Infections

Interventions

DRUG: Empagliflozin / Linagliptin or Dapagliflozin/Saxagliptin Pill
DRUG: Empagliflozin or Dapagliflozin Pill

Sponsor

University of Pisa